QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma,ย modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Convinistafetten 2025, a great evening filled with team spirit!
๐โโ๏ธYesterday a strong team from Quantify participated in convinistafetten in Stockholm. Well done everyone and thanks to Mathias Lilja for the support!
Good luck to everyone running today!
Quantify at the ISPE Annual Meeting 2025!
The 41st annual meeting at International Society for Pharmacoepidemiology is approaching. We are pleased to announce our attendance and participation in the upcoming program at the Walter E. Washington Convention Center, Washington DC, USA. August 22-26:
๐ข Presentation โ Emilie Toresson Grip and Kirk Geale, PhD โ ๐๐ฏ๐ต๐ฆ๐จ๐ณ๐ข๐ต๐ช๐ฏ๐จ ๐๐ฆ๐ข๐ญ-๐๐ฐ๐ณ๐ญ๐ฅ ๐๐ข๐ต๐ข ๐ธ๐ช๐ต๐ฉ ๐๐ข๐ฏ๐ฅ๐ฐ๐ฎ๐ช๐ป๐ฆ๐ฅ ๐๐ฐ๐ฏ๐ต๐ณ๐ฐ๐ญ๐ญ๐ฆ๐ฅ ๐๐ณ๐ช๐ข๐ญ๐ด: ๐๐ฅ๐ท๐ข๐ฏ๐ค๐ช๐ฏ๐จ ๐๐ท๐ช๐ฅ๐ฆ๐ฏ๐ค๐ฆ ๐๐ฆ๐ฏ๐ฆ๐ณ๐ข๐ต๐ช๐ฐ๐ฏ, Sunday August 24th, 1:30-3:00 PM.
๐ข Debate โ [โฆ]
Quantify warmly welcomes Isabella to the team!
We are excited to welcome Isabella Sundelin to the Quantify Research team as our new HR Generalist.
Isabella has a Bachelor of Science in Personnel, Work and Organization from Stockholm University. She began her career in recruitment and has spent the past four years in a broad HR role.
๐ Isabella is excited to join a company that values people and culture, and looks forward to contributing to its continued growth.
[โฆ]
๐Multiple sclerosis, EBV & Nordic data recognised at ECTRIMS
Excited to share that our Danish-Swedish real-world study has been selected for the ๐๐๐๐ ๐๐๐ฌ๐ญ ๐จ๐ ๐๐๐๐๐๐๐ slide deck โ highlighting it as one of this yearโs top abstracts.
The abstract, co-authored by Jonas Banefelt and Mathias Lilja, explores the link between Epstein-Barr virus-induced mononucleosis and the later risk of multiple sclerosis, using nationwide observational data.
Weโre proud to see this collaboration with Moderna and our methodological work recognised at such [โฆ]
